biomedicina slovenica


pr=Coates : 24

  1. Coates Paul M; Betz Joseph M; Blackman Marc R; Cragg Gornon M; Levine Marc; Moss Joel; White Jeffrey D
    Encyclopedia of dietary supplements (2nd ed)
    2010
  2. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008
  3. Viale Giuseppe; Giobbie-Hurder Anita; Regan Meredith M; Coates Alan S; Mastropasqua Mauro G; Dell'Orto Patrizia; Maiorano Eugenio; MacGrogan Gaetan; Braye Stephen G; Čufer Tanja
    Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
    2008
  4. Colleoni M; Li SZ; Gelber Richard D; Coates Alan S; Castiglione-Gertsch M; Price Karen; Lindtner Jurij; Rudenstam Carl-Magnus; Crivellari Diana; Collins Joseph; Pagani Olivia; Simoncini E.; Thürlimann Beat; Murray Elizabeth; Forbes John Alexander; Eržen Darja; Holmberg Stig B.; Veronesi A.; Goldhirsch Aron; Plesničar Andrej; Majdič Elga; Štabuc Borut; Golouh Rastko; Lamovec Janez; Jančar Janez; Vrhovec Ivan; Kramberger Marta; Novak Janez; Naglas M; Senčar Mojca; Červek Jožica; Šebek Slava; Cerar Olga; Čufer Tanja
    Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer
    2005
  5. Hamajima N; Hirose K; Tajima K; Rohan T; Coates RJ; Liff JM; Košmelj K; Primic-Žakelj M; Ravnihar B; Stare J
    Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83 000 women with breast cancer from 16 countries
    2004
  6. Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A
    Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?
    2003
  7. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002
  8. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001
  9. Calle EE; Heath CW-Jr; Miracle-McMahill HL; Coates RJ; Liff JM; Franceschi S; Košmelj K; Primic-Žakelj M; Ravnihar B; Stare J
    Breast cancer and hormonal contraceptives: further results
    1996
  10. Gelber Shari; Coates Alan A; Goldhirsch Aron; Castiglione-Gertsch Monica; Marini Gianluigi; Lindtner Jurij; Edelmann David Z; Gudgeon Anne; Harvey Vernon; Gelber Richard D
    Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer
    2001
  11. Vodušek DB; Bemelmans B; Chancellor M; Coates K; van Kerrebroeck P; Opsomer RJ; Schmidt R; Swash M
    Clinical neurophysiology
    2001
  12. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000
  13. Colleoni Marco; O'Neill Anne; Goldhirsch Aron; Gelber Richard D; Bonetti Marco; Thuerlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Lindtner Jurij
    Identifying breast cancer patients at high risk for bone metastases
    2000
  14. Colleoni Marco; Bonetti Marco; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    2000
  15. Crivellari Diana; Bonetti Marco; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Thuerlimann Beat; Price Karen N; Coates Alan S; Huerny Christoph; Lindtner Jurij
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International breast cancer study group Trial VII
    2000
  16. Hurny Christoph; Bernhard Juerg; Coates Alan; Peterson Harriet F; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Collins John; Lindtner Jurij; Goldhirsch Aron; Senn Hans-Joerg
    Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an International adjuvant breast cancer trial
    1996
  17. Vodušek DB; Bemelmans B; Chancellor M; Coates K; van Kerrebroeck P; Opsomer RJ; Schmidt R; Swash M
    Clinical neurophysiology
    1999
  18. Colleoni M; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Coates A; Thuerlimann B; Lindtner J; Collins J; Goldhirsch A
    Dose-response effect of adjuvant cyclophosphamide, methotrexate, fluorouracil in node-positive breast cancer
    1998
  19. Pagani O; O'Neil A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam C-M; Lindtner J; Collins J; Crivellari D; Coates A
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998
  20. Beral V; Calle EE; Heath CW; Coates RJ; Liff JM; Franceschi S; Košmelj K; Primic-Žakelj M; Ravnihar B; Stare J
    Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
    1997
  21. Calle EE; Heath CW; Miracle-McMahill HL; Coates RJ; Liff JM; Franceschi S; Košmelj K; Primic-Žakelj M; Ravnihar B; Stare J
    Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies
    1996
  22. Crivellari D; Price KN; Hagen M; Goldhirsch A; Gelber RD; Castiglione M; Coates AS; Rudenstam C-M; Collins J; Lindtner J
    Routine tests during follow-up of patients after primary treatment for operable breast cancer
    1995
  23. Macfarlane GJ; McCredie M; Pompe-Kirn V; Sharpe L; Coates M
    Second cancers occurring after cancers of the mouth and pharynx: data from three population-based registries in Australia, Scotland and Slovenia
    1995
  24. Goldhirsch A; Gelber RD; Price KN; Castiglione M; Coates AS; Rudenstam C-M; Collins J; Lindtner J; Hacking A; Marini G
    Effect of systemic adjuvant treatment on first sites of breast cancer relapse
    1994


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics